Literature DB >> 16896271

Continuous improvement of arterial compliance beyond blood pressure decrease after 5 years of antihypertensive treatment.

Claudio A Bellido1, Oscar R Iavicoli, Eduardo J Rusak, Sonia T Vazquez, Daniel J Piñeiro, Jorge Lerman.   

Abstract

Pulse wave velocity is a reliable marker of arterial compliance. Stiffness of large and elastic arteries leads to a faster propagation of pulse wave. The aim of this study was to evaluate changes in arterial distensibility using antihypertensive drugs. This treatment focused on the inhibition of the renin-angiotensin-aldosterone system and the changes produced in blood pressure. Measurements were taken at baseline and throughout 60 months in 66 previously untreated hypertensive patients (22 men and 44 women, aged 54 +/- 9.5 years, range 38-73 years at baseline). All patients received either angiotensin-converting enzyme inhibitors or, in case of adverse effects, angiotensin receptor blockers. To control blood pressure, diuretics, calcium channel blocking agents, or beta blockers were added when appropriate. Statistical analysis was performed by means of ANOVA with alpha = 0.05. Systolic and diastolic blood pressure decreased during the first year without significant changes thereafter. There were no significant changes in pulse pressure. Pulse wave velocity showed a continuous and significant decrease throughout the follow-up period, but its reduction since the third year was more evident than the decrease in systolic and diastolic blood pressure (p < 0.0001 for both). This observation could be related to changes in arterial remodeling probably due to angiotensin-converting enzyme inhibition or renin angiotensin system blockade. Further investigations are needed to establish this relationship.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896271      PMCID: PMC8109742          DOI: 10.1111/j.1524-6175.2006.05342.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

1.  Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age.

Authors:  S Meaume; A Benetos; O F Henry; A Rudnichi; M E Safar
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

2.  Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.

Authors:  R G Asmar; G M London; M E O'Rourke; M E Safar
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

Review 3.  Structural and genetic bases of arterial stiffness.

Authors:  Stéphane Laurent; Pierre Boutouyrie; Patrick Lacolley
Journal:  Hypertension       Date:  2005-04-25       Impact factor: 10.190

4.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

Authors:  G H Gibbons; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.

Authors:  Pierre Boutouyrie; Anne Isabelle Tropeano; Roland Asmar; Isabelle Gautier; Athanase Benetos; Patrick Lacolley; Stéphane Laurent
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

6.  Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?

Authors:  Kennedy Cruickshank; Lisa Riste; Simon G Anderson; John S Wright; Graham Dunn; Ray G Gosling
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

Review 7.  Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angiotensin system.

Authors:  J L Izzo
Journal:  Blood Press Monit       Date:  2000       Impact factor: 1.444

8.  Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  Michael Domanski; Gary Mitchell; Marc Pfeffer; James D Neaton; James Norman; Kenneth Svendsen; Richard Grimm; Jerome Cohen; Jeremiah Stamler
Journal:  JAMA       Date:  2002 May 22-29       Impact factor: 56.272

9.  Relation between insulin and aortic stiffness: a population-based study.

Authors:  T W Hansen; J Jeppesen; S Rasmussen; H Ibsen; C Torp-Pedersen
Journal:  J Hum Hypertens       Date:  2004-01       Impact factor: 3.012

10.  Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats.

Authors:  P Albaladejo; H Bouaziz; M Duriez; P Gohlke; B I Levy; M E Safar; A Benetos
Journal:  Hypertension       Date:  1994-01       Impact factor: 10.190

View more
  2 in total

Review 1.  Vascular effects of antihypertensive drug therapy.

Authors:  Asia Rehman; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Assessment of endothelial function by means of flow-mediated changes using pulse wave velocity.

Authors:  Eduardo J Rusak; Claudio A Bellido; Oscar R Iavicoli; Sonia T Vazquez; Mariano Duarte; Jorge Lerman
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.